Top Markets
#1 Akedo Akedo +82.13%
#2 Glidr Glidr +51.75%
#3 DOVU DOVU +48.35%
#4 Cross Cross +45.57%
#5 Black Phoenix Black Phoenix +34.20%
#6 Velvet Velvet +32.22%
#7 Cap Cap +21.97%
#8 OVERTAKE OVERTAKE +20.36%
#9 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +16.80%
#10 QANplatform QANplatform +14.83%
Coin of the day
Akedo Akedo
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
Lipidor AB (publ) Lipidor AB (publ)

Lipidor AB (publ)

LIPI
Kedudukan dalam Saham #39102
Lipidor AB (publ), a Swedish pharmaceutical company founded in Danderyd in... Lipidor AB (publ), a Swedish pharmaceutical company founded in Danderyd in 2009, specializes in developing medicinal products. Its core business centers on creating treatments for various skin conditions, including psoriasis, bacterial skin infections, and atopic dermatitis. The company's product pipeline includes AKP-01, which is currently in Phase III clinical trials for psoriasis, while other formulations like AKP-02 (also for psoriasis) and AKP-03 and AKP-07 (for eczema) are in earlier, preclinical development stages. Beyond its own drug candidates, Lipidor manufactures and supplies active pharmaceutical ingredients (APIs). These APIs are incorporated into products addressing a broad spectrum of therapeutic applications, such as managing psoriasis, microbial infections, inflammation, fungal issues, local pain relief, acne, wound healing, eczema, and migraines. Lipidor also caters to the animal health market, offering a line of spray-on skin care products for dogs, cats, and horses. Additionally, it develops consumer health items designed for purposes like antibacterial action, antiseptic care, moisturizing, disinfection, and treating acne and warts. In a key strategic alliance, Lipidor has partnered with Cannassure Therapeutics Ltd. This collaboration aims to advance topical medicinal cannabis products specifically formulated to alleviate skin inflammations and psoriatic lesions.
Harga Saham
$0.02243487
Disegerakkan terakhir: 2025-06-04
Modal Pasaran
$650.09K
Perubahan (1 hari)
0.39%
Perubahan (1 tahun)
0.00%
Negara
SE
Perdagangan Lipidor AB (publ) (LIPI)

Kategori

Healthcare
EPS untuk Lipidor AB (publ) (LIPI)
EPS setakat December 2024 TTM: $-0.01
Menurut laporan kewangan terkini dan harga saham Lipidor AB (publ), EPS semasa syarikat (TTM) adalah $-0.01. Pada akhir tahun 2023, syarikat mempunyai EPS sebanyak $-0.04 penurunan berbanding EPS tahun 2022 iaitu $-0.14.
Sejarah EPS untuk Lipidor AB (publ) dari 2016 hingga 2026
EPS pada akhir setiap tahun
Tahun EPS Ubah
2026 (TTM) $-0.01 -92.68%
2024 0.00 -92.68%
2023 $-0.04 -70.93%
2022 $-0.14 66.50%
2021 $-0.08 2.38%
2020 $-0.08 9.75%
2019 $-0.07 54.89%
2018 $-0.05 125.96%
2017 $-0.02 -29.97%
2016 $-0.03 0.00%
EPS untuk syarikat atau pesaing yang serupa
Syarikat EPS Perbezaan EPS Negara
Eli Lilly and Company Eli Lilly and Company
Eli Lilly and Company
LLY.US
 $29.85 -328,121.98%
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
 $8.65 -95,154.95%
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
 $3.55 -39,110.99%
US
Roche Holding AG Roche Holding AG
Roche Holding AG
RO.SW
 $20.39 -224,154.95%
CH
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
 $1.26 -13,946.15%
US